(+/-)-isoampelopsin D | 1001258-93-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: (+/-)-isoampelopsin D
• 英文别名: (±)-isoampelopsin；3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-1-[(4-hydroxyphenyl)methyl]-3H-indene-4,6-diol
• CAS: 1001258-93-0
• 化学式: C₂₈H₂₂O₆
• 分子量: 454.479
• InChiKey: HRIJITRLXFENGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  34
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  121
• 氢给体数：
  6
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  在 甲醇 、 potassium cyanide 作用下， 生成 (+/-)-isoampelopsin D
  参考文献：
  名称：

  基于白藜芦醇的天然产物的全合成：化学选择性溶液。

  摘要：

  DOI：

  10.1002/anie.200703333

文献信息

• Nazarov Cyclization of Divinyl and Arylvinyl Epoxides: Application in the Synthesis of Resveratrol-Based Natural Products
  作者：Gangarajula Sudhakar、Kovela Satish

  DOI：10.1002/chem.201500362

  日期：2015.4.20

  New variation in the Nazarov cyclization has been developed by preparing divinyl and arylvinyl epoxides as pentadienyl cation precursors for the first time. Highly substituted cyclopentadienes, hydrindienes, and indenes were synthesized to demonstrate the compatibility of this reaction with substrates bearing a variety of substitutions and having different types of epoxides. Application of this method

  通过首次将二乙烯基和芳基乙烯基环氧化物制备为戊二烯基阳离子前体，已开发出Nazarov环化的新变化形式。合成了高度取代的环戊二烯，羟基和茚基，以证明该反应与带有各种取代基和环氧化物类型不同的底物的相容性。还证明了该方法在合成以白藜芦醇为基础的天然产物中的应用。
• 2-Phenyl indene derivatives useful as estrogen receptor ligands
  申请人：Jernstedt Henrik

  公开号：US20090326018A1

  公开（公告）日：2009-12-31

  The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity. Formula (I), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are as defined in the specification, and wherein either the bond between the C1 and C2 carbon atoms is a double bond or the bond between the C2 and C3 carbon atoms is a double bond, R 2 being absent when the bond between the C1 and C2 carbon atoms is a double bond.

  本发明提供了化合物(I)或其药学上可接受的酯、酰胺、溶剂合物或盐，包括这种酯或酰胺的盐，以及这种酯、酰胺或盐的溶剂合物。本发明还提供了在与雌激素受体活性相关的疾病或紊乱的情况下使用这些化合物进行治疗或预防的方法。其中，化合物(I)的R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和R12如规范中所定义，在C1和C2碳原子之间的键是双键或C2和C3碳原子之间的键是双键时，R2不存在。